Literature DB >> 15011771

Clinical inertia: errors of omission in drug therapy.

Amanda G Kennedy1, Charles D MacLean.   

Abstract

Mesh：

Year:  2004        PMID： 15011771     DOI： 10.1093/ajhp/61.4.401

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  4 in total

1.  Laboratory monitoring of drugs at initiation of therapy in ambulatory care.

Authors:  Marsha A Raebel; Ella E Lyons; Susan E Andrade; K Arnold Chan; Elizabeth A Chester; Robert L Davis; Jennifer L Ellis; Adrianne Feldstein; Margaret J Gunter; Jennifer Elston Lafata; Charron L Long; David J Magid; Joseph V Selby; Steven R Simon; Richard Platt
Journal:  J Gen Intern Med       Date:  2005-12       Impact factor: 5.128

2.  Understanding and improving management of inpatient diabetes mellitus: the Mayo Clinic Arizona experience.

Authors:  Curtiss B Cook; Richard S Zimmerman; Susanne M Gauthier; Janna C Castro; Kimberly A Jameson; Stephanie D Littman; Janice M Magallanez
Journal:  J Diabetes Sci Technol       Date:  2008-11

3.  Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin.

Authors:  Michael L Parchman; Jacqueline A Pugh; Raquel L Romero; Krista W Bowers
Journal:  Ann Fam Med       Date:  2007 May-Jun       Impact factor: 5.166

Review 4.  The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review.

Authors:  Jean-Pierre Lebeau; Jean-Sébastien Cadwallader; Isabelle Aubin-Auger; Alain Mercier; Thomas Pasquet; Emmanuel Rusch; Kristin Hendrickx; Etienne Vermeire
Journal:  BMC Fam Pract       Date:  2014-07-02       Impact factor: 2.497
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.